Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Valeritas Holdings Inc (VLRX)

Valeritas Holdings Inc (VLRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,140
  • Shares Outstanding, K 8,332
  • Annual Sales, $ 26,400 K
  • Annual Income, $ -45,930 K
  • 60-Month Beta 1.72
  • Price/Sales 0.05
  • Price/Cash Flow N/A
  • Price/Book 0.17
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -11.64
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/03/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -4.00
  • Growth Rate Est. (year over year) +25,075.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.25 +2.72%
on 02/19/20
0.84 -69.43%
on 01/21/20
-0.54 (-67.69%)
since 01/17/20
3-Month
0.25 +2.72%
on 02/19/20
1.84 -86.04%
on 12/11/19
-1.24 (-82.88%)
since 11/19/19
52-Week
0.25 +2.72%
on 02/19/20
11.39 -97.75%
on 03/05/19
-7.74 (-96.79%)
since 02/19/19

Most Recent Stories

More News
Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees

Valeritas Holdings, Inc. (NASDAQ: VLRX) ("Valeritas" or the "Company"), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, today announced an agreement to sell substantially...

VLRX : 0.26 (-9.32%)
ZEAL : 37.93 (-3.26%)
Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarter and Full Year

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, today announced revised...

VLRX : 0.26 (-9.32%)
Valeritas Presents Positive h-Patch(TM) CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 Annual Meeting

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced positive data...

VLRX : 0.26 (-9.32%)
Valeritas' V-Go(R) Wearable Insulin Delivery Device Demonstrates Reductions in A1c and Daily Insulin Usage

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go Wearable Insulin Delivery device, today announced additional data from the VERDICT study presented at the 19 Annual...

VLRX : 0.26 (-9.32%)
Valeritas Announces Third Quarter 2019 Financial Results

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes,...

VLRX : 0.26 (-9.32%)
Valeritas Presents Positive h-Patch(TM) Apomorphine Study Data at the World Congress of Neurology (WCN 2019)

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced positive data...

VLRX : 0.26 (-9.32%)
Valeritas to Report Third Quarter 2019 Financial Results on November 12, 2019

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go(R) Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, today announced that...

VLRX : 0.26 (-9.32%)
GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary h-Patch(TM) Wearable Device in Preclinical Study

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses their proprietary h-Patch(TM) technology, announced today positive...

VLRX : 0.26 (-9.32%)
Valeritas Presents Positive h-Patch(TM) Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer's Disease & Dementia

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced positive data...

VLRX : 0.26 (-9.32%)
Valeritas Announces Poster Presentation of Preclinical h-Patch(TM) Cannabidiol (CBD) Study at the American Epilepsy Society's Annual Meeting

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced today a poster...

VLRX : 0.26 (-9.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade VLRX with:

Business Summary

Valeritas Holdings Inc. is a commercial-stage medical technology company which focused on developing technologies for Type 2 diabetes. The company's product pipeline consists of V-Go (R) Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for Type 2 diabetes...

See More

Key Turning Points

2nd Resistance Point 0.34
1st Resistance Point 0.30
Last Price 0.26
1st Support Level 0.23
2nd Support Level 0.21

See More

52-Week High 11.39
Fibonacci 61.8% 7.14
Fibonacci 50% 5.82
Fibonacci 38.2% 4.51
Last Price 0.26
52-Week Low 0.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar